Sign In

Pierce Ogden

Co-Founder and CSO at Manifold Bio

Pierce Ogden is the Co-Founder and Chief Scientific Officer (CSO) at Manifold Bio, a biotechnology company specializing in the design of precision biologics. He has been with Manifold Bio since its inception in 2019, where he has played a pivotal role in developing the company's innovative protein M-Codes technology. This technology allows for advanced measurements of protein therapeutics in vivo, significantly enhancing drug discovery processes.13

Educational Background

Pierce Ogden earned his Doctor of Philosophy (Ph.D.) in Biological and Biomedical Sciences from Harvard University in 2019. His academic journey also includes a Bachelor of Science degree in Biochemistry and Molecular Biology from the University of San Francisco.15

Professional Experience

Before co-founding Manifold Bio, Ogden held several notable positions:

  • Postdoctoral Research Fellow at the Wyss Institute for Biologically Inspired Engineering, where he focused on using DNA libraries and machine learning to develop next-generation protein therapeutics.12
  • PhD Candidate in the George Church Lab at Harvard Medical School, where he worked on engineering viral structures and immune system responses for gene therapy applications.12
  • Assistant Specialist at the Small Molecule Discovery Center at UCSF, where he developed assays for identifying new compound interactions.15

Contributions to Biotechnology

At Manifold Bio, Ogden has led efforts to create extensive protein binder and M-Code libraries using machine learning and advanced DNA synthesis techniques. His work has contributed to raising approximately $45 million in funding to support the company's growth and technological advancements.136

Ogden's research focuses on leveraging synthetic biology to enhance drug development, particularly through the use of adeno-associated viruses (AAVs) for gene therapy. His pioneering work aims to improve the delivery mechanisms of these therapies, making them safer and more effective.24

Overall, Pierce Ogden's expertise in synthetic biology and high-throughput methods positions him as a key figure in advancing the field of biotechnology and therapeutic development.

Highlights

Oct 7 · theorg.com
Pierce Ogden - Co-Founder & CSO at Manifold Bio | The Org
Pierce Ogden - Co-Founder & CSO at Manifold Bio | The Org
Manifold Biotechnologies Inc. (Manifold Bio) - Life-Sciences-USA.com
‪Pierce Ogden‬ - ‪Google Scholar‬
Jul 14 · businesswire.com
Manifold Bio Raises $40 Million Series A to Expand In Vivo ...
Jul 14 · The Boston Globe
Manifold Bio raises $40m for 'protein barcoding' technology to make drug testing in animals more efficient - The Boston Globe
Jul 14 · The Boston Globe
George Church startup Manifold Bio raises $40m for ‘protein barcoding’ technology to improve drug testing - The Boston Globe
George Church startup Manifold Bio raises $40m for ‘protein barcoding’ technology to improve drug te
Jun 13 · leadiq.com
Manifold Bio Company Overview, Contact Details & Competitors ...
Oct 26 · fiftyyears.com
Translation Podcast - Evolving AAVs for Gene Therapy with Pierce ...

Related Questions

What are the key achievements of Pierce Ogden at Manifold Bio?
How does Pierce Ogden's work at Manifold Bio impact gene therapy?
What technological advancements has Pierce Ogden contributed to synthetic biology?
Can you explain the role of DNA barcodes in Pierce Ogden's research?
What is the significance of Pierce Ogden's work with adeno-associated viruses (AAVs)?
Pierce Ogden
Pierce Ogden, photo 1
Pierce Ogden, photo 2
Add to my network

Location

Greater Boston